Regeneron VGFT-OD-0605, VIEW1 Study

A Randomized, Double Masked, Active Controlled Phase III Study of the Efficacy, Safety, and Tolerability of Repeated Doses of Intravitreal VEGF Trap in Subjects with Neovascular Age-Related Macular Degeneration. 

 

This trial tests the efficacy of a new treatment (VEGF Trap) in the treatment of wet macular degeneration compared to the current standard treatment of this disease (ranibizumab).  

 

 

   Retina Center

Minnesota

 

Contact Us

Tel: (612) 871-2292

       (800) 233-8504

Fax: (612) 871-0195

staff@retinadocs.com